Immix Biopharma (Nasdaq: IMMX) · 2 weeks ago
Commercial Biopharma Data Management & Systems Lead (Cell Therapy)
Immix Biopharma is a clinical-stage biopharmaceutical company focused on innovative cell therapies. They are seeking a Commercial Biopharma Data Management & Systems Lead to drive the design of commercial biopharmaceutical systems, ensuring accurate and integrated business-critical data across systems.
Biotechnology
Responsibilities
Lead Commercial Data Management Strategy: Act as the primary point of contact for Commercial Data Management within the US Commercial team, aligning with global data standards, technologies and strategy
Partner with US Senior Commercial Management, to identify business requirements, design IT solutions, and prioritize data-related initiatives
Data Integration & Quality: Ensure seamless integration of master data across systems, business processes, and applications, maintaining data consistency, integrity, and regulatory compliance
Vendor & Stakeholder Management: Support vendor management activities, monitor performance, and coordinate migration activities to ensure seamless transitions
Data Stewardship Oversight: Manage and guide third-party data stewardship activities, ensuring quality control and timely resolution of any data-related issues
Process Optimization: Drive the design and implementation of optimized MDM processes across commercial applications and business workflows
Continuous Improvement: Lead initiatives to improve data management practices, enhance data quality, and foster a culture of data excellence within the commercial team
Qualification
Required
Bachelor's degree
3-5+ years designing, implementing, and integrating/coding commercial data management solutions/strategies at a biopharmaceutical company that is commercializing in the U.S
Strong communication (written and verbal) and interpersonal skills
Demonstrate effective presentation skills by clearly explaining complex concepts to a broad range of audiences
Ability to independently prioritize tasks with excellent time management skills
Company
Immix Biopharma (Nasdaq: IMMX)
Immix Biopharma, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$124.1MKey Investors
GOOSE CapitalMesa Verde Venture Partners
2025-12-07Post Ipo Equity· $100M
2025-09-08Post Ipo Equity· $9.1M
2024-02-05Post Ipo Equity· $15M
Recent News
2026-01-11
Company data provided by crunchbase